ArticleInternational journal of immunogenetics2025

A Prospective Pilot Study to Investigate Whether Donor-Derived Cell-Free DNA Can Be Used as a Biomarker of Recurrent IgA Nephropathy Post-Kidney Transplantation.

Judith Owusuwaah Asiedu-Basoah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.